TABLE 1.
Demographic data of study population
| Variable | All women (n = 373) | Endometriosis (n = 94) | No abnormal ultrasound findings (n = 178) | Other abnormal ultrasound findings (n = 81) | p value |
|---|---|---|---|---|---|
| Age (years) | 30 (16–51) | 33 (22–50) | 27 (16–49) | 30 (16–50) | <0.0001 |
| Parity | 0 (0–7) | 0 (0–4) | 0 (0–7) | 0 (0–3) | 0.202 |
| Number of deliveries | |||||
| Nullipara | 258 (69) | 60 (64) | 126 (71) | 63 (78) | |
| 1 | 42 (11) | 17 (18) | 14 (8) | 7 (9) | |
| 2 | 56 (15) | 14 (15) | 31 (17) | 8 (10) | |
| 3 | 11 (3) | 1 (1) | 4 (2) | 3 (4) | |
| ≥4 | 6 (2) | 2 (2) | 3 (2) | 0 (0) | |
| Infertility | 64 (17) | 31 (33) | 13 (7) | 16 (20) | <0.0001 |
| Current hormonal treatment | 183 (49) | 39 (42) | 100 (56) | 36 (44) | 0.040 |
| Systemic progestins | 48 (26) | 7 (18) | 34 (34) | 6 (17) | |
| COC or vaginal contraceptive ring | 83 (45) | 19 (49) | 46 (46) | 12 (33) | |
| Hormonal intrauterine device | 32 (18) | 6 (15) | 13 (13) | 12 (33) | |
| GnRH analogs | 4 (2) | 2 (5) | 0 (0) | 2 (6) | |
| Combination of treatments a | 13 (7) | 4 (10) | 7 (7) | 2 (6) | |
| Other b | 3 (2) | 1 (3) | 0 (0) | 2 (6) | |
| Median length of use of hormonal treatment (months) | 8 (1–240) | 5 (1–48) | 11 (1–240) | 9 (1–180) | 0.027 |
| Dysmenorrhea | 373 (100) | 94 (100) | 178 (100) | 81 (100) | 0.008 |
| Severity of dysmenorrhea c | n = 352 | n = 86 | n = 169 | n = 79 | |
| VAS | 76 (7–100) | 67 (8–100) | 76 (7–100) | 79 (14–100) | 0.030 |
| Severe (VAS 71–100) | 197 (56) | 38 (44) | 94 (56) | 51 (65) | |
| Chronic pelvic pain | 289 (78) | 68 (72) | 144 (81) | 61 (75) |
0.244 |
| Dyspareunia | 302 (81) | 69 (73) | 152 (85) | 66 (82) |
0.024 |
| Dysuria | 208 (56) | 42 (45) | 108 (61) | 47 (58) |
0.032 |
| Dyschezia | 286 (77) | 66 (70) | 141 (79) | 63 (78) | 0.194 |
Data are given as n (%) or as median (range). p values are given from comparison between women with endometriosis, no abnormal ultrasound findings and other abnormal ultrasound findings. Women with isolated adenomyosis at ultrasound (n = 20) are not shown in this table.
Abbreviations: COC, combined oral contraceptives; GnRH, gonadotropin‐releasing hormone; VAS, visual analog scale.
a
Combination of hormonal intrauterine device with systemic hormonal treatment or combination of two systemic treatments.
b
Esmya or progestin cream.
c
Given as number of women who reported severity of dysmenorrhea according to visual analog scale.